RPTX (Repare Therapeutics Inc.) Stock Market Reviews

crown

search

Read and share opinions on RPTX (Repare Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

RPTX

Repare Therapeutics Inc.

clarify Biotechnology

bookmark Healthcare

public Canada

Sell Neutral Buy

Latest News

Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3
Nov 14, 2025
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Nov 14, 2025
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oct 13, 2025
Repare Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Aug 10, 2025
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
Aug 8, 2025
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Aug 8, 2025
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
Jul 15, 2025
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
May 13, 2025
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
May 1, 2025
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
Apr 25, 2025
Repare Therapeutics Announces Leadership Transitions
Mar 31, 2025
What Makes Repare Therapeutics (RPTX) a New Buy Stock
Mar 11, 2025
Repare Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Mar 4, 2025

Reviews